FundedIQ
Biotechnology

Solugen: Funding, Investors & Team (Sep 2026)

Solugen is a biotech company supported by investors that aims to replace products made from petroleum with alternatives derived from plants. By blending fermentation and petrochemical processing techniques, they have developed a platform for carbon-negative molecular manufacturing. Their technology converts bio-based feedstocks into chemicals using innovative methods in synthetic biology, metal catalyst engineering, and modular plant design. Solugen's solutions not only contribute to cleaner water, sustainable materials, and safer food, but also support healthy personal care.

solugen.com LinkedIn Houston, United States 101-250 employees
Biopharma Biotechnology Chemical GreenTech Manufacturing B2B B2C
Total raised
$414M
Rounds
2
Latest
Undisclosed round
Jun 2024

Solugen has raised $414M across 2 funding rounds on record, the most recent an undisclosed round of $214M announced in Jun 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Solugen Company Profile and Key Stats

Total funding raised
$414M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$214M in Jun 2024
Employees
101-250
reported band
Headquarters
Houston, United States

Latest funding round on record: Jun 2024.

Solugen Funding Rounds

Date
Round
Amount
Undisclosed round
$214M
Series D
$200M

Solugen raised $200M in a Series D announced in Nov 2022.

1.6 years later, an undisclosed round of $214M was announced in Jun 2024.

Solugen Founders and Leadership Team

Name
Role
Contact
Gaurab Chakrabarti
Founder

No contact details are on record for this team yet.

Solugen Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

Solugen's latest round of $214M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Solugen in Biotechnology and Houston

Companies Similar to Solugen

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Solugen Funding FAQs

What does Solugen do?

Solugen is a biotech company supported by investors that aims to replace products made from petroleum with alternatives derived from plants. By blending fermentation and petrochemical processing techniques, they have developed a platform for carbon-negative molecular manufacturing. Their technology converts bio-based feedstocks into chemicals using innovative methods in synthetic biology, metal catalyst engineering, and modular plant design. Solugen's solutions not only contribute to cleaner water, sustainable materials, and safer food, but also support healthy personal care.

How much funding has Solugen raised?

Solugen has raised $414M across 2 rounds on record. The most recent is an undisclosed round of $214M announced in Jun 2024.

When did Solugen last raise funding?

Solugen's most recent funding round on record is an undisclosed round of $214M, announced in Jun 2024.

Who founded Solugen?

FundedIQ lists Gaurab Chakrabarti (Founder) at Solugen.

Where is Solugen headquartered?

Solugen is based in Houston, Texas, United States.

How many employees does Solugen have?

Solugen is in the 101-250 employee band.

How does Solugen's funding compare to other Biotechnology startups?

Solugen's latest round of $214M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Solugen Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Solugen is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.